Search Results - Rouvio, O

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    P-287 Infectious events are much more prevalent following a seven compared to five days cycle of azacitidine regardless of patient's age

    P-287 Infectious events are much more prevalent following a seven compared to five days cycle of azacitidine regardless of patient's age by Ofran, Y, Filanovsky, K, Gafter-Gvili, A, Vidal, L, Aviv, A, Gatt, M.E, Silbershatz, I, Herishanu, Y, Arad, A, Tadmor, T, Dally, N, Nemets, A, Rouvio, O, Ronson, A, Herzog-Tzarfati, K, Akria, L, Braester, A, Hellmann, I, Yeganeh, S, Nagler, A, Leiba, R, Mittelman, M, Merkel, D

    Published in Leukemia research
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study

    Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study by Muchtar, Eli, Gatt, Moshe E., Rouvio, Ory, Ganzel, Chezi, Chubar, Evgeni, Suriu, Celia, Tadmor, Tamar, Shevetz, Olga, Lavi, Noa, Shochat, Tzippy, Cohen, Yael C., Avivi, Irit, Raanani, Pia, Magen, Hila

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Primary plasma cell leukemia in the era of novel agents for myeloma – a multicenter retrospective analysis of outcome

    Primary plasma cell leukemia in the era of novel agents for myeloma – a multicenter retrospective analysis of outcome by Ganzel, Chezi, Rouvio, Ory, Avivi, Irit, Magen, Hila, Jarchowsky, Osnat, Herzog, Katrin, Cohen, Yossi, Tadmor, Tamar, Horwitz, Netanel A., Leiba, Merav, Nagler, Arnon, Cohen, Yael, Bulvik, Shlomo, Polliack, Aaron, Rowe, Jacob M., Gatt, Moshe E.

    Published in Leukemia research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    PS1399 REAL WORLD DATA ON THE EFFICACY AND SAFETY OF DARATUMUMAB FOR TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY AL AMYLOIDOSIS: A MULTI‐SITE RETROSPECTIVE STUDY

    PS1399 REAL WORLD DATA ON THE EFFICACY AND SAFETY OF DARATUMUMAB FOR TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY AL AMYLOIDOSIS: A MULTI‐SITE RETROSPECTIVE STUDY by Shragai, T., Gatt, M., Lavie, N., Vaxman, I., Tadmor, T., Rouvio, O., Zektser, M., Levi, S., Avivi, I., Cohen, Y.C.

    Published in HemaSphere
    Request full text
    Article
    Save to List
    Saved in:
  5. 5
    Self HSP60 peptide serves as an immunogenic carrier for a CTL epitope against persistence of murine cytomegalovirus in the salivary gland

    Self HSP60 peptide serves as an immunogenic carrier for a CTL epitope against persistence of murine cytomegalovirus in the salivary gland by Rouvio, Ory, Dvorkin, Tatyana, Amir-Kroll, Hila, Atias, Danit, Cohen, Irun R., Rager-Zisman, Bracha, Porgador, Angel

    Published in Vaccine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: